You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 23, 2024

Claims for Patent: 6,423,319

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,423,319

Title:	Methods for treating muscle injuries
Abstract:	Methods for treating an injured muscle by local administration of a neurotoxin, such as a botulinum toxin, to promote healing and/or to reduce the pain associated with an injured muscle.
Inventor(s):	Brooks; Gregory F (Irvine, CA), Aoki; Kei R. (Coto de Caza, CA)
Assignee:	Allergan Sales, Inc. (Irvine, CA)
Application Number:	09/678,189
Patent Claims:	1. A method for treating an injured muscle, the method comprising the step of local administration of a therapeutically effective amount of a botulinum toxin to an injured muscle, thereby treating the injured muscle by promoting healing of the injured muscle within six weeks after the local administration of the botulinum toxin. 2. The method of claim 1, wherein the botulinum toxin is intramuscularly injected. 3. The method of claim 1, wherein the botulinum toxin immobilizes the injured muscle. 4. The method of claim 1, wherein the botulinum toxin is effective to immobilize the injured muscle during phase 1 and phase 2 of a repair process of the injured muscle. 5. The method of claim 1, wherein the botulinum toxin is effective to immobilize the injured muscle during phase 1 of a repair process of the injured muscle. 6. The method of claim 1, wherein the botulinum toxin is selected from the group consisting of botulinum toxin type A, B, C.sub.1, D, E, F, and G. 7. The method of claim 1, wherein the botulinum toxin is a recombinantly made botulinum toxin. 8. The method of claim 1, further comprising the step of treating the injured muscle with reparative surgery. 9. The method of claim 1, wherein the botulinum toxin is botulinum toxin type A. 10. The method of claim 1, wherein the botulinum toxin is botulinum toxin type B. 11. A method for treating an injured muscle, the method comprising the step of local administration of a therapeutically effective amount of a botulinum toxin type A to an injured muscle, thereby treating the injured muscle by promoting healing of the injured muscle within six weeks after the local administration of the botulinum toxin type A.

Details for Patent 6,423,319

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Solstice Neurosciences, Llc	MYOBLOC	rimabotulinumtoxinb	Injection	103846	12/08/2000	⤷ Try a Trial	2039-02-26
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.